Could Fingolimod Combined with Bevacizumab Be a New Hope in Glioblastoma Treatment?
Glioblastoma, classified as a grade IV astrocytoma, is an aggressive and malignant primary brain tumor with no known cure. Despite the implementation of standard medical and surgical treatment protocols, the disease often progresses with unsatisfactory outcomes. This study aimed to evaluate the cyto...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2025-05-01
|
| Serija: | Current Issues in Molecular Biology |
| Teme: | |
| Online pristup: | https://www.mdpi.com/1467-3045/47/6/394 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|